I was excited to hear at the Alliance for CME annual conference about the community's new advocacy initiatives, and in particular, the drive to collect data to demonstrate CME's positive impact on patient care and to determine the prevalence of commercial bias. CME leaders were forthright in acknowledging that they don't know what the data will show — it may, in fact, reveal that the Senate Finance Committee and other critics are correct in their assessment that commercial support erodes CME
Register to view the full article
Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.
0 comments
Hide comments